The dual recognition reflects Invengene’s progress as a growing pharmaceutical organisation built on disciplined execution, strong quality systems, and a clear focus on bringing complex science into practical, scalable solutions for global markets.

Invengene’s win as Pharma MSME of the Year acknowledges the company’s consistent focus on doing the fundamentals well: strong development practices, quality-first operations, and dependable delivery. Over the past year, the organisation has strengthened its end-to-end ways of working across R&D, regulatory, and cross-functional execution, with a clear emphasis on building repeatable systems that support both speed and compliance.

For Invengene, MSME is not just a category of size. It represents the ability to build with focus, move with intent, and deliver with accountability.

Vaibhavi Shah’s recognition as Emerging Women Icon of the Year celebrates her leadership in building science teams, raising the bar on development discipline, and pushing for innovation that stays grounded in patient need and real-world manufacturability. As a co-founder and the leader of Invengene’s R&D agenda, she has helped shape a culture where scientific integrity is non-negotiable and long-term thinking is valued as much as near-term outcomes.

Her approach is defined by clarity of thought, high standards, and an ability to turn complex problems into structured, executable plans. Under her leadership, Invengene continues to strengthen its product development engine and build differentiated capabilities aligned with global expectations.

These awards reinforce Invengene’s direction: building a science-led organisation that partners globally, executes reliably, and stays anchored to its purpose: Simplifying Science, Together. The company will continue investing in capabilities that support development excellence, quality maturity, and sustainable growth across regulated and emerging markets.